These and other studies showing that Myo10-positive filopodia promote the migration of metastatic cancer cells [65], together with the data presented here, provide strong justification for performing screens to identify inhibitors of Myo10 as possible cancer therapeutics. The gene discussed is MYO10; the disease is cancer.